Pasadena, CA, United States of America

Csl Behring Gene Therapy, Inc.


USPTO Granted Patents = 5

% Expired Patents = 20.0


Forward Citations = 4

Loading Chart...
Loading Chart...

10 inventors (with patents filed for the assignee):

goldMedal Jeffrey S Bartlett (4 out of 6 patents)

silverMedal Geoffrey Phillip Symonds (4 out of 15 patents)

bronzeMedal Chi-Lin Lee (3 out of 4 patents)

4.  Ming Yan (3 out of 12 patents)

5.  Jeffrey Ahlers (2 out of 2 patents)

6.  Gene-Errol Eugenio Ringpis (2 out of 2 patents)

7.  Christopher Walter Alma (1 out of 2 patents)

8.  Louis Randall Breton (1 out of 2 patents)

9.  Anthony Dominic Kelleher (1 out of 6 patents)

10.  Kazuo Suzuki (1 out of 2 patents)


5 patents:

Company Overview
CSL Behring Gene Therapy is a leading biotechnology company focused on developing innovative gene therapies for rare diseases. With a mission to transform patients' lives, CSL Behring Gene Therapy is committed to advancing cutting-edge research and development in the field of genetic medicine. Through collaboration with leading scientists and healthcare professionals, CSL Behring Gene Therapy aims to bring new treatment options to patients in need.
Profile summary synthesized from public USPTO records and patent filings.

logo

Company Badge

USPTO Data Jan 1 1976 - Oct 6 2026

5 Patents

#94 in Pasadena, CA

#12,058 in California

#51,570 in US

Pasadena, CA (US)
Pasadena, CA, United States of America
Forward Citations = 4

10 inventors:

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Csl Behring Gene Therapy, Inc.. Retrieved from https://idiyas.com/company/csl-behring-gene-therapy

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…